Philmore Robertson

Philmore Robertson

UNVERIFIED PROFILE

Are you Philmore Robertson?   Register this Author

Register author
Philmore Robertson

Philmore Robertson

Publications by authors named "Philmore Robertson"

Are you Philmore Robertson?   Register this Author

37Publications

557Reads

14Profile Views

Identification and human exposure prediction of two aldehyde oxidase-mediated metabolites of a methylquinoline-containing drug candidate.

Xenobiotica 2019 Mar 14;49(3):302-312. Epub 2018 Mar 14.

a Department of Drug Metabolism and Pharmacokinetics , Teva Pharmaceuticals , West Chester , PA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/00498254.2018.1
Publisher Site
http://dx.doi.org/10.1080/00498254.2018.1444815DOI Listing
March 2019

Metabolite profiling of C-omacetaxine mepesuccinate in plasma and excreta of cancer patients.

Xenobiotica 2016 Dec 21;46(12):1122-1132. Epub 2016 Mar 21.

a Department of Pharmacy and Pharmacology , Antoni Van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart , Amsterdam , The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00498254.2016.1152418DOI Listing
December 2016

Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumors.

Invest New Drugs 2016 10 25;34(5):565-74. Epub 2016 May 25.

Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0360-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007276PMC
October 2016

Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites.

Cancer Chemother Pharmacol 2015 Jun 1;75(6):1143-54. Epub 2015 Apr 1.

Sci-Med Bridge, LLC, 1916 General Alexander Drive, Malvern, PA, 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2727-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441746PMC
June 2015

Dose proportionality of a hydrocodone extended-release tablet formulated with abuse-deterrence technology.

Clin Drug Investig 2015 May;35(5):291-7

Teva Pharmaceuticals, 41 Moores Road, PO Box 4011, Frazer, PA, 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-015-0280-zDOI Listing
May 2015

Evaluation of the potential for pharmacokinetic drug-drug interaction between armodafinil and carbamazepine in healthy adults.

Clin Ther 2015 Feb 16;37(2):325-37. Epub 2014 Oct 16.

Teva Pharmaceuticals, West Chester, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2014.09.014DOI Listing
February 2015

Evaluation of the potential for a pharmacokinetic drug-drug interaction between armodafinil and ziprasidone in healthy adults.

Clin Drug Investig 2014 Oct;34(10):691-9

Sci-Med Bridge, LLC, 1916 General Alexander Drive, Malvern, PA, 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-014-0220-3DOI Listing
October 2014

Investigation of a possible interaction between quetiapine and armodafinil in patients with schizophrenia: an open-label, multiple-dose study.

J Clin Pharmacol 2012 Sep 8;52(9):1399-409. Epub 2011 Sep 8.

Clinical Pharmacology Department, Cephalon, Inc., 41 Moores Road, Frazer, PA 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270011414572DOI Listing
September 2012

Metabolite profiling of bendamustine in urine of cancer patients after administration of [14C]bendamustine.

Drug Metab Dispos 2012 Jul 4;40(7):1297-307. Epub 2012 Apr 4.

Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dmd.aspetjournals.org/cgi/doi/10.1124/dmd.112.045229
Publisher Site
http://dx.doi.org/10.1124/dmd.112.045229DOI Listing
July 2012

Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies.

Clin Drug Investig 2009 ;29(2):87-100

Clinical Pharmacology Department, Cephalon, Inc., Frazer, Pennsylvania 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/0044011-200929020-00003DOI Listing
March 2009

Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate.

J Clin Pharmacol 2007 Mar;47(3):343-50

Cephalon Inc., 41 Moores Road, Frazer, PA 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270006297749DOI Listing
March 2007

Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers.

J Clin Pharmacol 2007 Jan;47(1):56-63

Clinical Pharmacology, Cephalon, Inc., Frazer, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270006294129DOI Listing
January 2007

Clinical pharmacokinetic profile of modafinil.

Clin Pharmacokinet 2003 ;42(2):123-37

Department of Drug Safety and Disposition, Cephalon, Inc, West Chester, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00003088-200342020-00002DOI Listing
April 2003

Steady-state pharmacokinetics and tolerability of modafinil administered alone or in combination with dextroamphetamine in healthy volunteers.

J Clin Pharmacol 2002 Apr;42(4):450-60

Department of Drug Disposition, Cephalon, Inc., West Chester, Pennsylvania 19380, USA.

View Article

Download full-text PDF

Source
April 2002

Effect of modafinil at steady state on the single-dose pharmacokinetic profile of warfarin in healthy volunteers.

J Clin Pharmacol 2002 Feb;42(2):205-14

Department of Drug Disposition, Cephalon, Inc., West Chester, Pennsylvania 19380, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/00912700222011120DOI Listing
February 2002

Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers.

Clin Pharmacol Ther 2002 Jan;71(1):46-56

Department of Drug Disposition, Cephalon, Inc., West Chester, PA 19380, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/mcp.2002.121217DOI Listing
January 2002